Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Reiberger

Showing results (191-200 of 491) with videos related to

Pageof 50
Sort By:
United European Gastroenterology Journal|May 9, 2019
High efficacy of interferon-free therapy for acute hepatitis C in HIV-positive patientsDavid Chromy, Mattias Mandorfer, Theresa Bucsics, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 25, 2018
Dysbalanced sex hormone status is an independent predictor of decompensation and mortality in patients with liver cirrhosisRafael Paternostro, Birgit B Heinisch, Thomas Reiberger, et al.
Plos One|June 13, 2024
Statins, metformin, and RAS inhibitors did not reduce variceal bleeding risk and mortality in a large, real-life cohort of patients with cirrhosisNikolaus Pfisterer, Michael Schwarz, Caroline Schwarz, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 15, 2011
Portal pressure predicts outcome and safety of antiviral therapy in cirrhotic patients with hepatitis C virus infectionThomas Reiberger, Karoline Rutter, Arnulf Ferlitsch, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 4, 2015
Risk factors for development of spontaneous bacterial peritonitis and subsequent mortality in cirrhotic patients with ascitesPhilipp Schwabl, Theresa Bucsics, Kathrin Soucek, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 24, 2014
New reliability criteria for transient elastography increase the number of accurate measurements for screening of cirrhosis and portal hypertensionPhilipp Schwabl, Simona Bota, Petra Salzl, et al.
United European Gastroenterology Journal|July 11, 2024
Evolution of liver function during immune checkpoint inhibitor treatment for hepatocellular carcinomaKatharina Pomej, Lorenz Balcar, Sabrina Sidali, et al.
AIDS (London, England)|December 15, 2012
Low vitamin D levels are associated with impaired virologic response to PEGIFN + RBV therapy in HIV-hepatitis C virus coinfected patientsMattias Mandorfer, Thomas Reiberger, Berit A Payer, et al.
Alimentary Pharmacology & Therapeutics|August 28, 2025
Clinical Features of Portal Hypertension and Their Prognostic Implications in Patients With Autoimmune HepatitisLukas Burghart, Sonja Treiber, David Bauer, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 30, 2013
Health-related quality of life and severity of fatigue in HIV/HCV co-infected patients before, during, and after antiviral therapy with pegylated interferon plus ribavirinMattias Mandorfer, Berit A Payer, Bernhard Scheiner, et al.
Pageof 50

Showing results (191-200 of 491) with videos related to

Sort By:
Pageof 50
United European Gastroenterology Journal|May 9, 2019
High efficacy of interferon-free therapy for acute hepatitis C in HIV-positive patientsDavid Chromy, Mattias Mandorfer, Theresa Bucsics, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 25, 2018
Dysbalanced sex hormone status is an independent predictor of decompensation and mortality in patients with liver cirrhosisRafael Paternostro, Birgit B Heinisch, Thomas Reiberger, et al.
Plos One|June 13, 2024
Statins, metformin, and RAS inhibitors did not reduce variceal bleeding risk and mortality in a large, real-life cohort of patients with cirrhosisNikolaus Pfisterer, Michael Schwarz, Caroline Schwarz, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 15, 2011
Portal pressure predicts outcome and safety of antiviral therapy in cirrhotic patients with hepatitis C virus infectionThomas Reiberger, Karoline Rutter, Arnulf Ferlitsch, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 4, 2015
Risk factors for development of spontaneous bacterial peritonitis and subsequent mortality in cirrhotic patients with ascitesPhilipp Schwabl, Theresa Bucsics, Kathrin Soucek, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 24, 2014
New reliability criteria for transient elastography increase the number of accurate measurements for screening of cirrhosis and portal hypertensionPhilipp Schwabl, Simona Bota, Petra Salzl, et al.
United European Gastroenterology Journal|July 11, 2024
Evolution of liver function during immune checkpoint inhibitor treatment for hepatocellular carcinomaKatharina Pomej, Lorenz Balcar, Sabrina Sidali, et al.
AIDS (London, England)|December 15, 2012
Low vitamin D levels are associated with impaired virologic response to PEGIFN + RBV therapy in HIV-hepatitis C virus coinfected patientsMattias Mandorfer, Thomas Reiberger, Berit A Payer, et al.
Alimentary Pharmacology & Therapeutics|August 28, 2025
Clinical Features of Portal Hypertension and Their Prognostic Implications in Patients With Autoimmune HepatitisLukas Burghart, Sonja Treiber, David Bauer, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 30, 2013
Health-related quality of life and severity of fatigue in HIV/HCV co-infected patients before, during, and after antiviral therapy with pegylated interferon plus ribavirinMattias Mandorfer, Berit A Payer, Bernhard Scheiner, et al.
Pageof 50